Nadolol for Prevention of Variceal Rebleeding in Cirrhosis: A Controlled Clinical Trial
Angelo Gatta(University of Padua), A. Ruol(University of Padua), Massimo Bolognesi(University of Padua), Lorenza Caregaro(University of Padua), R Zuin(University of Padua), David Sacerdoti(University of Verona), Carlo Merkel(University of Padua), Paolo Angeli(European Association for the Study of Diabetes)
Cited by 69
Related Papers
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
|Journal of Hepatology|2018|2.8k
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites
|Journal of Hepatology|2015|864
Reversal of Type 1 Hepatorenal Syndrome With the Administration of Midodrine and Octreotide
|Hepatology|1999|560
Nutrition and survival in patients with liver cirrhosis
|Nutrition|2001|514